These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8887982)

  • 1. The role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--II NAN-190 and SDZ 216-525.
    Sharp T; Umbers V; Hjorth S
    Neuropharmacology; 1996 Jun; 35(6):735-41. PubMed ID: 8887982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
    Sharp T; McQuade R; Fozard JR; Hoyer D
    Br J Pharmacol; 1993 Jul; 109(3):699-702. PubMed ID: 8102935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin.
    Hjorth S; Bengtsson HJ; Milano S; Lundberg JF; Sharp T
    Neuropharmacology; 1995 Jun; 34(6):615-20. PubMed ID: 7566497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924.
    Bengtsson HJ; Kullberg A; Millan MJ; Hjorth S
    Neuropharmacology; 1998; 37(3):349-56. PubMed ID: 9681933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function.
    Routledge C; Hartley J; Gurling J; Ashworth-Preece M; Brown G; Dourish CT
    Neuropharmacology; 1994; 33(3-4):359-66. PubMed ID: 7984274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
    Routledge C; Gurling J; Ashworth-Preece MA; Dourish CT
    Eur J Pharmacol; 1995 Apr; 276(3):281-4. PubMed ID: 7601215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RU 24969-induced locomotion in rats is mediated by 5-HT1A receptors.
    Kalkman HO
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):583-4. PubMed ID: 8751090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
    Schoeffter P; Fozard JR; Stoll A; Siegl H; Seiler MP; Hoyer D
    Eur J Pharmacol; 1993 Feb; 244(3):251-7. PubMed ID: 8384569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties.
    Assié MB; Koek W
    Eur J Pharmacol; 1996 May; 304(1-3):15-21. PubMed ID: 8813579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists.
    Schreiber R; Brocco M; Gobert A; Veiga S; Millan MJ
    Eur J Pharmacol; 1994 Dec; 271(2-3):537-41. PubMed ID: 7705455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
    Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological analysis of the hypothermic effects of NAN-190 and its analogs, postsynaptic 5-HT1A receptor antagonists, in mice.
    Wesołowska A; Borycz J; Paluchowska MH; Chojnacka-Wójcik E
    Pol J Pharmacol; 2002; 54(4):391-9. PubMed ID: 12523493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.